Terminated × Neoplasms, Glandular and Epithelial × Clear all
NCT03769467 2024-11-14

Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)

Atara Biotherapeutics

Phase 1/2 Terminated
12 enrolled 8 charts
NCT01215578 2015-04-30

NET

Assistance Publique - HĂ´pitaux de Paris

Phase 2 Terminated
33 enrolled